UTHR-a Promising Biotech in the works here? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : UTHR-a Promising Biotech in the works here?

UTHR 445.43

-1.8%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: debra vogt who wrote (13)	8/20/1999 4:54:00 AM
From: red_dog	Read Replies (1) of 66

kendall I have followed some of your post on Market Gems in the past, and figured that I owed you a couple of bucks for some of the picks that I made a few dollars on. <bg> So I dug up a few facts to answer Debra's question, I hope it will be of help. Positive results in phase II study of its lead compound, UT-15, in patients with mild to moderate hepatic impairment associated with Portopulmonary Hypertension. (a well-recognized complication of chronic liver disease) Without checking I would venture to say there are not a lot of people in need,(this in no way is to say that it isn't important) but would have to check further to get a specific number. Now pulmonary hypertension effects mostly young women and is the leading cause of lung transplants. Just found this information: Approximately 50,000 people are estimated to be diagnosed with life threatening pulmonary hypertension. Many of these are said to have developed the disease as a result of taking the diet drugs Redux and Phen-fen. To some up with what I have found so far. The primary therapies for these patients today are lung transplants or lifelong, 24 hour-a-day intravenous of a drug called prostacyclin. UT-15 therapy is intended to be a safer subcutaneous formulation of prostacyclin. I know that doesn't answer all of your question but it's been a while since I had to do an essay on unfamiliar subject. <bg> Flash! Found some more information: I have just found that UT-15 had positive results in phase II in patients with moderate to severe peripheral vascular disease (PVD). A disease that affects more than 2 million people in North America. I believe that you will find that number to be very much larger in the far east. This is only my opinion! Rg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next